China · Delayed Price · Currency is CNY Winner Medical Statistics
Total Valuation
Winner Medical has a market cap or net worth of CNY 24.05 billion. The enterprise value is 23.73 billion.
| Market Cap | 24.05B |
| Enterprise Value | 23.73B |
Important Dates
The last earnings date was Tuesday, October 28, 2025.
| Earnings Date | Oct 28, 2025 |
| Ex-Dividend Date | Sep 3, 2025 |
Share Statistics
Winner Medical has 582.33 million shares outstanding. The number of shares has decreased by -0.69% in one year.
| Current Share Class | 582.33M |
| Shares Outstanding | 582.33M |
| Shares Change (YoY) | -0.69% |
| Shares Change (QoQ) | -1.47% |
| Owned by Insiders (%) | 70.43% |
| Owned by Institutions (%) | 8.13% |
| Float | 162.73M |
Valuation Ratios
The trailing PE ratio is 27.56 and the forward PE ratio is 23.09.
| PE Ratio | 27.56 |
| Forward PE | 23.09 |
| PS Ratio | 2.23 |
| PB Ratio | 1.96 |
| P/TBV Ratio | 2.61 |
| P/FCF Ratio | 32.12 |
| P/OCF Ratio | 16.20 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.01, with an EV/FCF ratio of 31.69.
| EV / Earnings | 27.14 |
| EV / Sales | 2.20 |
| EV / EBITDA | 14.01 |
| EV / EBIT | 21.63 |
| EV / FCF | 31.69 |
Financial Position
The company has a current ratio of 1.69, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.69 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.63 |
| Debt / FCF | 3.69 |
| Interest Coverage | 15.33 |
Financial Efficiency
Return on equity (ROE) is 7.63% and return on invested capital (ROIC) is 4.61%.
| Return on Equity (ROE) | 7.63% |
| Return on Assets (ROA) | 3.77% |
| Return on Invested Capital (ROIC) | 4.61% |
| Return on Capital Employed (ROCE) | 8.12% |
| Revenue Per Employee | 690,762 |
| Profits Per Employee | 55,895 |
| Employee Count | 15,642 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 2.82 |
Taxes
In the past 12 months, Winner Medical has paid 247.01 million in taxes.
| Income Tax | 247.01M |
| Effective Tax Rate | 21.00% |
Stock Price Statistics
The stock price has increased by +30.82% in the last 52 weeks. The beta is 0.30, so Winner Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | +30.82% |
| 50-Day Moving Average | 39.77 |
| 200-Day Moving Average | 42.23 |
| Relative Strength Index (RSI) | 67.04 |
| Average Volume (20 Days) | 5,782,713 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Winner Medical had revenue of CNY 10.80 billion and earned 874.31 million in profits. Earnings per share was 1.50.
| Revenue | 10.80B |
| Gross Profit | 4.99B |
| Operating Income | 1.10B |
| Pretax Income | 1.18B |
| Net Income | 874.31M |
| EBITDA | 1.47B |
| EBIT | 1.10B |
| Earnings Per Share (EPS) | 1.50 |
Balance Sheet
The company has 3.85 billion in cash and 2.76 billion in debt, giving a net cash position of 1.09 billion or 1.87 per share.
| Cash & Cash Equivalents | 3.85B |
| Total Debt | 2.76B |
| Net Cash | 1.09B |
| Net Cash Per Share | 1.87 |
| Equity (Book Value) | 12.26B |
| Book Value Per Share | 19.88 |
| Working Capital | 3.46B |
Cash Flow
In the last 12 months, operating cash flow was 1.48 billion and capital expenditures -735.99 million, giving a free cash flow of 748.83 million.
| Operating Cash Flow | 1.48B |
| Capital Expenditures | -735.99M |
| Free Cash Flow | 748.83M |
| FCF Per Share | 1.29 |
Margins
Gross margin is 46.20%, with operating and profit margins of 10.15% and 8.09%.
| Gross Margin | 46.20% |
| Operating Margin | 10.15% |
| Pretax Margin | 10.89% |
| Profit Margin | 8.09% |
| EBITDA Margin | 13.63% |
| EBIT Margin | 10.15% |
| FCF Margin | 6.93% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.21%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 1.21% |
| Dividend Growth (YoY) | -22.22% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 52.17% |
| Buyback Yield | 0.69% |
| Shareholder Yield | 1.90% |
| Earnings Yield | 3.64% |
| FCF Yield | 3.11% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 2, 2023. It was a forward split with a ratio of 1.4.
| Last Split Date | Jun 2, 2023 |
| Split Type | Forward |
| Split Ratio | 1.4 |
Scores
Winner Medical has an Altman Z-Score of 3.83 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.83 |
| Piotroski F-Score | 6 |